Showing results (1631-1640 of 3,105) with videos related to

Sort By:
Pageof 311
Drug Safety|December 14, 2004
Safety issues regarding colonic cleansing for diagnostic and surgical proceduresLarry E Clark, Jack A Dipalma
Drug Safety|January 15, 2005
Atypical antipsychotics: from potassium channels to torsade de pointes and sudden deathKarine Titier, Pierre-Olivier Girodet, Hélène Verdoux, et al.
Drug Safety|January 15, 2005
Hepatotoxicity of antiretrovirals: incidence, mechanisms and managementMarina Núñez, Vincent Soriano
Drug Safety|March 1, 2005
Tolerability of paracetamolGarry G Graham, Kieran F Scott, Richard O Day
Drug Safety|March 1, 2005
Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapyAlexandra E Rätz Bravo, Lydia Tchambaz, Anita Krähenbühl-Melcher, et al.
Drug Safety|May 15, 2004
Do some inhibitors of COX-2 increase the risk of thromboembolic events?: Linking pharmacology with pharmacoepidemiologyDavid W J Clark, Deborah Layton, Saad A W Shakir
Drug Safety|May 18, 2004
Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agentsJoan-Ramon Laporte, Luisa Ibáñez, Xavier Vidal, et al.
Drug Safety|May 25, 2004
Communication of medical product risk: how effective is effective enough?Stephen A Goldman
Drug Safety|May 25, 2004
Clinical pharmacology: special safety considerations in drug development and pharmacovigilanceKwame N Atuah, Dyfrig Hughes, Munir Pirmohamed
Drug Safety|May 25, 2004
Current requirements and emerging trends for labelling as a tool for communicating pharmacovigilance findingsA Leander Fontaine
Pageof 311